Table 3.
Pathologic Findings (≥pT3 or Gleason >6 of Any Size) | |||
Epstein’s Clinical Criteria Alone | Significant Disease | Insignificant Disease | |
Significant Disease | 46 | 21 | PPV = 69% |
Insignificant Disease | 12 | 25 | NPV = 68% |
Sensitivity = 79% | Specificity = 54% | ||
Pathologic Findings (≥pT3 or Gleason >6 of Any Size) | |||
Epstein’s Clinical Criteria or ADC<850 µm2/sec | Significant Disease | Insignificant Disease | |
Significant Disease | 54 | 25 | PPV = 68% |
Insignificant Disease | 4 | 21 | NPV = 84% |
Sensitivity = 93% | Specificity = 46% | ||
Pathologic Findings (≥pT3, or Gleason ≥4+3, or Gleason 3+4 and ≥1.3 mL) | |||
Epstein’s Clinical Criteria Alone | Significant Disease | Insignificant Disease | |
Significant Disease | 44 | 23 | PPV = 66% |
Insignificant Disease | 10 | 27 | NPV = 73% |
Sensitivity = 82% | Specificity = 54% | ||
Pathologic Findings (≥pT3, or Gleason ≥4+3, or Gleason 3+4 and ≥1.3 mL) | |||
Epstein’s Clinical Criteria or ADC<850 µm2/sec | Significant Disease | Insignificant Disease | |
Significant Disease | 52 | 27 | PPV = 66% |
Insignificant Disease | 2 | 23 | NPV = 92% |
Sensitivity = 96% | Specificity = 46% |
Abbreviations as in Table 1.